We are live on ! Find out more
CLPT icon

ClearPoint Neuro
CLPT

21 hedge funds and large institutions have $4.2M invested in ClearPoint Neuro in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

24% more capital invested

Capital invested by funds: $3.4M → $4.2M (+$808K)

24% more funds holding

Funds holding: 17 → 21 (+4)

0.97% more ownership

Funds ownership: 4.79% → 5.76% (+0.97%)

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$363K
2
WVP
Worth Venture Partners
New Jersey
+$359K
3
MWM
Merriman Wealth Management
Washington
+$114K
4
RFC
Regions Financial Corp
Alabama
+$48.2K
5
Northern Trust
Northern Trust
Illinois
+$47.6K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$181K
2
Goldman Sachs
Goldman Sachs
New York
-$168K
3
Citadel Advisors
Citadel Advisors
Florida
-$52K
4
Morgan Stanley
Morgan Stanley
New York
-$4.36K
5
AG
Advisor Group
Arizona
-$1.24K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.59M +$363K +87,674 +36%
MWM
2
Merriman Wealth Management
Washington
$486K +$114K +27,496 +37%
WVP
3
Worth Venture Partners
New Jersey
$416K +$359K +86,725 New
Millennium Management
4
Millennium Management
New York
$343K -$181K -43,811 -38%
Bank of America
5
Bank of America
North Carolina
$244K – – –
MC
6
Mayo Clinic
Minnesota
$226K +$195K +47,148 New
KMC
7
Kirr Marbach & Co
Indiana
$212K +$4.14K +1,000 +2%
Brown Advisory
8
Brown Advisory
Maryland
$134K – – –
PCM
9
Parsons Capital Management
Rhode Island
$128K – – –
WJWM
10
Williams Jones Wealth Management
New York
$103K – – –
WMC
11
Westwood Management Corporation
Illinois
$84K – – –
RFC
12
Regions Financial Corp
Alabama
$56K +$48.2K +11,655 New
Northern Trust
13
Northern Trust
Illinois
$55K +$47.6K +11,503 New
BCM
14
Bridgeway Capital Management
Texas
$50K +$43.4K +10,500 New
BlackRock
15
BlackRock
New York
$37K +$32.2K +7,773 New
JP Morgan Chase
16
JP Morgan Chase
New York
$14K – – –
UBS Group
17
UBS Group
Switzerland
$14K +$11.6K +2,813 +2,147%
AG
18
Advisor Group
Arizona
$5K -$1.24K -300 -23%
Morgan Stanley
19
Morgan Stanley
New York
$2K -$4.36K -1,054 -68%
OIA
20
Optimum Investment Advisors
Illinois
$2K – – –
Goldman Sachs
21
Goldman Sachs
New York
– -$168K -33,206 Closed
Citadel Advisors
22
Citadel Advisors
Florida
– -$52K -10,268 Closed

CLPT Hedge Fund Activity: Q4 2019 in Review

21 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2019, worth a combined $4.2M — up 24% from $3.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CLPT positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $363K. The largest seller was Millennium Management, cutting an estimated $181K.

  • 21 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2019, up from 17 in Q3 2019.
  • Funds reported $4.2M of ClearPoint Neuro stock for Q4 2019, up 24% quarter-over-quarter.
  • 6 funds opened new ClearPoint Neuro positions in Q4 2019 and 2 closed out, a net change of +4 holders.
  • The largest ClearPoint Neuro buyer in Q4 2019 was Vanguard Group, an estimated $363K added.
  • The largest ClearPoint Neuro seller in Q4 2019 was Millennium Management, an estimated $181K sold.

Based on aggregated 13F filings for Q4 2019.